Sign in to fuzzto save your conversations, follow your research and come back anytime.
iSERA Lifesciences
SectorInformation Technology
| Metric (₹ crore) | Q4 FY15 | Q1 FY16 | Q2 FY16 | Q4 FY18 | Q1 FY19 | Q2 FY19 | Q3 FY19 | Q4 FY19 | Q1 FY20 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.24 | 4.43 | 6.24 | 13.79 | 10.43 | 7.42 | 4.21 | 3.62 | 1.11 |
| Expenses | 1.66 | 4.23 | 6.02 | 13.58 | 10.35 | 7.31 | 4.12 | 3.42 | 1.12 |
| EBITDA | 0.58 | 0.2 | 0.22 | 0.21 | 0.08 | 0.11 | 0.09 | 0.2 | -0.01 |
| Depreciation | 0.56 | 0.09 | 0.09 | 0.12 | 0 | 0.02 | 0.01 | 0.09 | 0 |
| EBIT | 0.02 | 0.11 | 0.13 | 0.09 | 0.08 | 0.09 | 0.08 | 0.11 | -0.01 |
| Interest | 0 | 0 | 0 | 0.09 | 0.05 | 0.11 | 0.09 | 0.13 | 0.06 |
| Profit Before Tax | 0.02 | 0.11 | 0.13 | 0 | 0.03 | -0.02 | -0.01 | -0.02 | -0.07 |
| Net Profit | 0.06 | 0.08 | 0.09 | 0 | 0.02 | -0.03 | -0.01 | -0.03 | -0.06 |
| EPS | 0.06 | 0.07 | 0.09 | 0 | 0.02 | 0 | -0.01 | -0.03 | -0.06 |
| Metric (₹ crore) | FY15 | FY16 | FY18 | FY19 |
|---|---|---|---|---|
| Operating Cash Flow | 0.49 | 0.81 | -0.65 | -0.33 |
| Investing Cash Flow | -1.16 | -0.4 | -0.16 | -0.38 |
| Financing Cash Flow | 0.69 | -0.42 | 0.8 | 1.13 |
| Net Cash Flow | 0.02 | -0.01 | -0.01 | 0.42 |
| Metric (₹ crore) | FY15 | FY16 | FY18 | FY19 |
|---|---|---|---|---|
| Equity / Shareholders' Funds | 13.97 | 0.55 | 0.54 | 0.49 |
| Total Liabilities | 10.85 | 13.92 | 19.39 | 17.17 |
| Total Assets | 24.82 | 14.47 | 19.93 | 17.66 |